CTRI/2023/01/048953尚未招募未知
Development of prediction model for potential drug-drug interactions between anti-tuberculosis drugs and co-medications among tuberculosis patients.
DR TMA PAI PhD FELLOWSHIP0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Tuberculosis patients who take anti-tuberculosis drugs and comedications
- •Tuberculosis patients aged 18 and above
排除标准
- •Patients with liver abnormalities based on abnormal liver function tests during admission
- •Pregnant and lactating tuberculosis patients
- •Mentally challenged tuberculosis patients
研究者
相似试验
招募中
不适用
Development of Prediction Model for Response to Biologics and Small Molecular Agent for UCKCT0006979Asan Medical Center300
尚未招募
不适用
Drug monitoring method for Dasatinib in blood cancer patientsCTRI/2020/09/027561Tata Memorial Centre
尚未招募
不适用
Development of pharmacokinetic model for the target-concentration controlled infusion of cefazolin used as a prophylactic antibiotic in surgical patientsDiseases of the digestive systemKCT0005963Asan Medical Center40
已完成
不适用
Development of pharmacokinetic model for the target-concentration controlled infusion of cefoxitin used as a prophylactic antibiotic in surgical patientsKCT0004442Asan Medical Center31
尚未招募
不适用
Development of prediction model for the efficacy of anti-PD-1 antibody on malignant pleural mesotheliomaMalignant pleural mesotheliomaJPRN-UMIN000034089Hyogo college of medicine50